TABLE 2.
Section | Topic | Studies informing recommendations, n (References) |
---|---|---|
I | Which populations are most appropriate for targeted testing of A1AT levels, to improve case-finding of patients at risk of or with documented lung disease associated with A1AT deficiency? | 7 (20–26) |
II | Is A1AT augmentation therapy effective in COPD patients with documented A1AT deficiency? | 6 (11,33–36,38) |
A1AT Alpha-1 antitrypsin; COPD Chronic obstructive pulmonary disease